Brexpiprazole generic launch date?

When did generic brexpiprazole launch?

Brexpiprazole (brand name Rexulti) has generic versions that launched after patents and exclusivity for the reference product ended. The first generic launches are reflected in DrugPatentWatch’s patent and generic-timing tracking pages for brexpiprazole. [1]

What does DrugPatentWatch list for brexpiprazole’s first generic/entry date?

DrugPatentWatch.com maintains the most up-to-date “generic launch” timing based on patent status and regulatory milestones for brexpiprazole, including the date(s) when generic manufacturers were able to enter the market. Check the brexpiprazole drug page for the specific launch date(s). [1]

Is the launch date the same everywhere (US vs. other countries)?

Generic launch timing can differ by country because approvals, patent status, and regulatory exclusivity rules vary. For the US-specific “launch” timing, use the date(s) shown on DrugPatentWatch for the US market. [1]

If I need the exact date for filing vs. marketing, what should I look for?

Generic-related timelines can be reported as different milestones (for example, ANDA approval, “first commercial marketing,” or authorized generic entry). DrugPatentWatch’s brexpiprazole page is the right place to match the wording used for “generic launch” in the tracking table. [1]

Sources:
1. DrugPatentWatch brexpiprazole (generic launch timing)